Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer

Clinical trial NCT00263588 · COMPLETED

Trial details

NCT number: NCT00263588
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2005-12-02
Primary completion: 2007-09-25
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.